<DOC>
	<DOCNO>NCT01933295</DOCNO>
	<brief_summary>Insomnia recognize prevalent `` costly '' sleep disorder associate considerable morbidity include significantly reduce quality life , impaired work performance , increase risk major depressive disorder.1-4 Insomnia key symptom menopausal transition . Cognitive-behavioral therapy insomnia ( CBT-I ) yield equivalent short-term efficacy superior long-term durability pharmacological treatment insomnia . The efficacy cognitive behavioral therapy insomnia comorbid menopause test .</brief_summary>
	<brief_title>Behavioral Treatment Menopausal Insomnia ; Sleep Daytime Outcomes</brief_title>
	<detailed_description>Specific Aim 1 : Determine efficacy multi-component CBT-I compare wait-list control group self report laboratory-based polysomnographic ( PSG ) sleep parameter . We hypothesize multicomponent CBT-I increase sleep efficiency , reduce frequency awakening , reduce wake sleep onset , increase sleep bout duration compare control group evaluate use polysomnographic ( PSG ) self-report measure sleep . Specific Aim 2a : Test efficacy brief two week single component sleep restriction therapy ( SRT ) wait-list control group PSG self-report sleep measure ( sleep efficiency , frequency awakening , wake sleep onset , sleep bout duration ) . We hypothesize brief SRT efficacious compare control condition woman menopausal-related insomnia . Specific Aim 2b : Test comparability ( non-inferiority analysis ) SRT CBT-I . We hypothesize SRT produce comparable efficacy term PSG self-report measure sleep compare CBT-I ( primary endpoint : sleep efficiency , frequency awakening , wake sleep onset , sleep bout duration ) . Specific Aim 3 : Determine CBT-I SRT improve specific aspect daytime functioning patient menopausal-related insomnia . We hypothesize patient treat CBT-I SRT great improvement depressive symptomatology , quality life , sleepiness fatigue compare wait list control group .</detailed_description>
	<criteria>postmenopausal insomnia unstable medical condition</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>treatment</keyword>
</DOC>